318 related articles for article (PubMed ID: 23717980)
21. Tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases.
Guo SK; Chen KJ; Qian ZH; Weng WL; Qian MY
Planta Med; 1983 Feb; 47(2):89. PubMed ID: 6844454
[No Abstract] [Full Text] [Related]
22. [Current quality research situation of precious Chinese patent medicine].
Lin L; Liu XQ; Xu H
Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):329-33. PubMed ID: 18536475
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone derivatives: a patent review (January 2006 - September 2012).
Tian XH; Wu JH
Expert Opin Ther Pat; 2013 Jan; 23(1):19-29. PubMed ID: 23094864
[TBL] [Abstract][Full Text] [Related]
24. The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases.
Li J; Gao Y; Ren X; Li Y; Wu L; Yang X; Wang J; Shang H; Xiong X; Xing Y
Curr Pharm Des; 2017; 23(7):1060-1069. PubMed ID: 27774897
[TBL] [Abstract][Full Text] [Related]
25. A novel classification method for aid decision of traditional Chinese patent medicines for stroke treatment.
Zhao Y; Liu B; He L; Bai W; Yu X; Cao X; Luo L; Rong P; Zhao Y; Li G; Liu B
Front Med; 2017 Sep; 11(3):432-439. PubMed ID: 28500428
[TBL] [Abstract][Full Text] [Related]
26. [Increasing dosage: a momentous proposition to improve therapeutic efficacy of traditional Chinese medicine].
Xiao XH; Yan D; Jin C; Zhao YL
Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):229-32. PubMed ID: 18536452
[TBL] [Abstract][Full Text] [Related]
27. Active chemical compounds of traditional Chinese medicine Herba Leonuri: implications for cardiovascular diseases.
Liu XH; Pan LL; Zhu YZ
Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):274-82. PubMed ID: 22004449
[TBL] [Abstract][Full Text] [Related]
28. [A survey and analysis of Chinese patent medicine for outpatients with chronic kidney disease].
Su GB; Liu XS; Weng JX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1074-9. PubMed ID: 21910338
[TBL] [Abstract][Full Text] [Related]
29. [Experimental study on two-way application of drugs with neutral property for promoting blood circulation and removing blood stasis on cold and heat blood stasis syndromes II].
Hao EW; Deng JG; Du ZC; Zheng ZW; Yang K; Wang Q; Tang YL; Bao CH; Lu XY; Tang ZL; Deng XQ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):605-10. PubMed ID: 23713291
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in Chinese patent medicines entering the international market.
Zhang B; Pei W; Cai P; Wang Z; Qi F
Drug Discov Ther; 2022 Dec; 16(6):258-272. PubMed ID: 36543180
[TBL] [Abstract][Full Text] [Related]
31. [Explore pros and cons of proproetary Chinese medicines and Western medicines].
Jin YQ; Jiang ZY
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2407-9. PubMed ID: 19157140
[TBL] [Abstract][Full Text] [Related]
32. [Mitochondrial dysfunction induced by excessive ROS/RNS-metabolic cardiovascular disease and traditional Chinese medicines intervention].
Zhang C; Liu J; Pan H; Yang X; Bian K
Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(17):2423-8. PubMed ID: 22121816
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of cardiovascular disease with Xiongshao capsule].
Yuan R; Wang Y; Cong WH; Chen KJ
Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(4):640-643. PubMed ID: 28959830
[TBL] [Abstract][Full Text] [Related]
34. [Key points for clinical orientation in the secondary development of famous and superior Chinese patent drugs].
Shang HC; Liu Y; Zhang JH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Oct; 28(10):939-40. PubMed ID: 19123337
[TBL] [Abstract][Full Text] [Related]
35. [Study of combination methods for formula composition of Chinese herbal medicines and their components].
Liu XJ; Su SB
Zhong Xi Yi Jie He Xue Bao; 2009 Jul; 7(7):601-6. PubMed ID: 19615311
[TBL] [Abstract][Full Text] [Related]
36. [Academic discussion of adverse reaction of clinical trials of new traditional Chinese medicines and relevant influencing factors].
Wang WP; Yu M; Wang L; Jiang XR; Li XB; Wang HW; Cao Y; Liu K; Huang LQ
Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(2):346-50. PubMed ID: 26080571
[TBL] [Abstract][Full Text] [Related]
37. Traditional Chinese medicine and oral diseases: today and tomorrow.
Zheng LW; Hua H; Cheung LK
Oral Dis; 2011 Jan; 17(1):7-12. PubMed ID: 20646230
[TBL] [Abstract][Full Text] [Related]
38. [Response to US review rules on patent subject matter of traditional Chinese medicine compositions].
Liu P; Cao YD; Gong RJ; Liu W
Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(3):627-630. PubMed ID: 29600632
[TBL] [Abstract][Full Text] [Related]
39. [Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world].
Yang W; Xie Y; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2779-82. PubMed ID: 22292363
[TBL] [Abstract][Full Text] [Related]
40. Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products.
Kartal M
Phytother Res; 2007 Feb; 21(2):113-9. PubMed ID: 17117452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
